title: Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study.
authors.affiliation: INSERM Unit U981, Institut Gustave Roussy, Villejuif, France Department of Oncological and Surgical Sciences, University of Padua, Padua Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
authors.forename: M V
authors.initials: MV
authors.lastname: Dieci
authors.affiliation: Early Drug Development for Innovative Therapies Division, Department of Medicine, Istituto Europeo di Oncologia, Milano.
authors.forename: C
authors.initials: C
authors.lastname: Criscitiello
authors.affiliation: INSERM Unit U981, Institut Gustave Roussy, Villejuif, France.
authors.forename: A
authors.initials: A
authors.lastname: Goubar
authors.affiliation: Department of Pathology, Istituto Europeo di Oncologia, Milano Faculty of Medicine, University of Milan, Milano.
authors.forename: G
authors.initials: G
authors.lastname: Viale
authors.affiliation: Department of Oncological and Surgical Sciences, University of Padua, Padua Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
authors.forename: P
authors.initials: P
authors.lastname: Conte
authors.affiliation: Department of Oncological and Surgical Sciences, University of Padua, Padua Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
authors.forename: V
authors.initials: V
authors.lastname: Guarneri
authors.affiliation: Division of Pathology, Modena University Hospital, Modena, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Ficarra
authors.affiliation: Departments of Medical Biology and Pathology.
authors.forename: M C
authors.initials: MC
authors.lastname: Mathieu
authors.affiliation: INSERM Unit U981, Institut Gustave Roussy, Villejuif, France Medical Oncology, Institut Gustave Roussy, Villejuif.
authors.forename: S
authors.initials: S
authors.lastname: Delaloge
authors.affiliation: Early Drug Development for Innovative Therapies Division, Department of Medicine, Istituto Europeo di Oncologia, Milano.
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.affiliation: INSERM Unit U981, Institut Gustave Roussy, Villejuif, France Medical Oncology, Institut Gustave Roussy, Villejuif Faculty of Medicine, Paris Sud University, Kremlin-Bicêtre, France.
authors.forename: F
authors.initials: F
authors.lastname: Andre